These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9782570)

  • 1. The search for the uremic toxin: the case for carbamoylation of amino acids and proteins.
    Kraus LM; Kraus AP
    Wien Klin Wochenschr; 1998 Aug; 110(15):521-30. PubMed ID: 9782570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamoylation of amino acids and proteins in uremia.
    Kraus LM; Kraus AP
    Kidney Int Suppl; 2001 Feb; 78():S102-7. PubMed ID: 11168993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis.
    Kraus LM; Elberger AJ; Handorf CR; Pabst MJ; Kraus AP
    J Lab Clin Med; 1994 Jun; 123(6):882-91. PubMed ID: 8201267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genesis of the uraemic syndrome: role of uraemic toxins.
    Hörl WH
    Wien Klin Wochenschr; 1998 Aug; 110(15):511-20. PubMed ID: 9782569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage.
    Kraus LM; Gaber L; Handorf CR; Marti HP; Kraus AP
    Swiss Med Wkly; 2001 Mar; 131(11-12):139-4. PubMed ID: 11416886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamoylation of hemoglobin in uremic patients determined by antibody specific for homocitrulline (carbamoylated epsilon-N-lysine).
    Kraus LM; Miyamura S; Pecha BR; Kraus AP
    Mol Immunol; 1991; 28(4-5):459-63. PubMed ID: 2062323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremia and insulin resistance: N-carbamoyl-asparagine decreases insulin-sensitive glucose uptake in rat adipocytes.
    Kraus LM; Traxinger R; Kraus AP
    Kidney Int; 2004 Mar; 65(3):881-7. PubMed ID: 14871407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential carbamoyl-amino acids formed in vivo in patients with end-stage renal disease managed by continuous ambulatory peritoneal dialysis: isolation, identification, and quantitation.
    Kraus LM; Jones MR; Kraus AP
    J Lab Clin Med; 1998 May; 131(5):425-31. PubMed ID: 9605107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamoylated free amino acids in uremia: HOCl generates volatile protein modifying and cytotoxic oxidant species from N-carbamoyl-threonine but not threonine.
    Schreier SM; Hollaus M; Hermann M; Jirovetz L; Exner M; Kapiotis S; Gmeiner BM; Laggner H
    Biochimie; 2012 Nov; 94(11):2441-7. PubMed ID: 22776434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein carbamylation links inflammation, smoking, uremia and atherogenesis.
    Wang Z; Nicholls SJ; Rodriguez ER; Kummu O; Hörkkö S; Barnard J; Reynolds WF; Topol EJ; DiDonato JA; Hazen SL
    Nat Med; 2007 Oct; 13(10):1176-84. PubMed ID: 17828273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the uremic toxin cyanate (CNO⁻) on anaerobic cysteine metabolism and oxidative processes in the rat liver: a protective effect of lipoate.
    Sokołowska M; Niedzielska E; Iciek M; Bilska A; Lorenc-Koci E; Włodek L
    Toxicol Mech Methods; 2011 Jul; 21(6):473-8. PubMed ID: 21417628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-carbamoylation impairs the oxidant scavenging activity of cysteine: its possible impact on increased LDL modification in uraemia.
    Schreier SM; Steinkellner H; Jirovetz L; Hermann M; Exner M; Gmeiner BM; Kapiotis S; Laggner H
    Biochimie; 2011 Apr; 93(4):772-7. PubMed ID: 21277933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amino acids and albumin on erythropoietin carbamoylation.
    Jin K
    Clin Exp Nephrol; 2013 Aug; 17(4):575-81. PubMed ID: 23229652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State analysis of endogenous cyanate ion in human plasma.
    Koshiishi I; Imanari T
    J Pharmacobiodyn; 1990 Apr; 13(4):254-8. PubMed ID: 2117063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and consequences of carbamoylation.
    Delanghe S; Delanghe JR; Speeckaert R; Van Biesen W; Speeckaert MM
    Nat Rev Nephrol; 2017 Sep; 13(9):580-593. PubMed ID: 28757635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamoylation of amino acid, peptides, and proteins by nitrosoureas.
    Wheeler GP; Bowdon BJ; Struck RF
    Cancer Res; 1975 Nov; 35(11 Pt 1):2974-84. PubMed ID: 1182691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.